Read more about how indirect treatment comparisons (NMA, MAIC, and STC) were used to compare the relative efficacy of inotuzumab ozogamicin and blinatumomab for the treatment of adults with relapsed/refractory B cell precursor acute lymphoblastic leukemia:
1,413 followers
5 followers
RT @evideraglobal: An NMA, STC, and MAIC were conducted to compare two therapies for the treatment of adults with relapsed or refractory B…
1,413 followers
An NMA, STC, and MAIC were conducted to compare two therapies for the treatment of adults with relapsed or refractory B cell precursor acute lymphoblastic leukemia. Learn more in this publication: https://t.co/9mZbv5sFLs https://t.co/hGGSEnXzjG